Protagonist Therapeutics
PTGX
₹4,790
Share price
-2.22%
Change (1 day)
47.40%
Change (1 year)
Categories
P/S ratio for Protagonist Therapeutics (PTGX)
P/S ratio as of July 2025 (TTM): 16.4
According to Protagonist Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.95. At the end of 2025 the company had a P/S ratio of 14.4.
P/S ratio history for Protagonist Therapeutics from 2016 to 2025
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 14.4 | 170.16% |
| 2024 | 5.34 | -75.75% |
| 2023 | 22.0 | 9.16% |
| 2022 | 20.2 | -66.16% |
| 2021 | 59.7 | 96.96% |
| 2020 | 30.3 | -96.35% |
| 2019 | 831 | 16361.66% |
| 2018 | 5.05 | -76.83% |
| 2017 | 21.8 | |
| 2016 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |